Fermata Advisors, LLC Pfizer Inc Transaction History

Fermata Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$25.26 - $29.6 $99,120 - $116,150	-3,924 Reduced 34.58%	7,424 $207,000
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $87,611 - $100,606	3,384 Added 42.49%	11,348 $314,000
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $17,480 - $22,705	-669 Reduced 7.75%	7,964 $229,000
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $277,032 - $323,823	8,633 New	8,633 $286,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $31,479 - $41,093	754 Added 9.15%	8,994 $461,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $17,810 - $21,741	-407 Reduced 4.71%	8,240 $361,000
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $101,993 - $120,932	2,192 Added 33.96%	8,647 $453,000
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $8,555 - $10,601	-187 Reduced 2.82%	6,455 $334,000
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $30,576 - $45,325	740 Added 12.54%	6,642 $392,000
Q3 2021 Oct 29, 2021	BUY	$39.25 - $50.42 $231,653 - $297,578	5,902 New	5,902 $254,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Fermata Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fermata Advisors, LLC with notifications on news.